Syndax Pharmaceuticals, Inc

(NASDAQ:SNDX)

Latest On Syndax Pharmaceuticals, Inc (SNDX):

Date/Time Type Description Signal Details
2023-05-09 04:24 ESTNewsSyndax Pharmaceuticals GAAP EPS of -$0.59 beats by $0.01N/A
2023-05-09 04:24 ESTNewsSyndax Pharmaceuticals, Inc. (SNDX) Q1 2023 Earnings Call TranscriptN/A
2023-05-08 02:38 ESTNewsSyndax Pharmaceuticals Q1 2023 Earnings PreviewN/A
2023-03-04 02:40 ESTNewsSyndax Pharmaceuticals, Inc. (SNDX) Q4 2022 Earnings Call TranscriptN/A
2023-03-01 16:35 ESTNewsSyndax Pharmaceuticals: 2023 Is A Pivotal YearN/A
2023-03-01 01:25 ESTNewsSyndax Pharmaceuticals GAAP EPS of -$0.62 beats by $0.04N/A
2023-02-27 19:50 ESTNewsSyndax Pharmaceuticals Q4 2022 Earnings PreviewN/A
2023-01-12 14:22 ESTNewsSyndax Pharmaceuticals (SNDX) Presents at the 41st Annual J.P. Morgan Healthcare Conference -- SlideshowN/A
2022-12-17 03:56 ESTNewsSyndax Pharmaceuticals (SNDX) Presents at 64th ASH Annual Meeting & ExpositionN/A
2022-12-12 19:48 ESTNewsKura Oncology falls, Syndax gains after Phase 1/2 data for leukemia candidatesN/A
2022-12-10 16:27 ESTNewsSyndax Pharmaceuticals: Today's Best Nearby Biotech Cap-Gain ProspectN/A
2022-12-07 20:58 ESTNewsSyndax Pharmaceuticals prices $150M offeringN/A
2022-12-07 01:27 ESTNewsSyndax Pharma to sell $150M stock in public offeringN/A
2022-12-05 14:27 ESTNewsSyndax receives breakthrough therapy tag for revumenib to treat acute leukemiaN/A
2022-11-06 14:31 ESTNewsSyndax Pharmaceuticals, Inc. (SNDX) Q3 2022 Earnings Call TranscriptN/A
2022-11-06 14:31 ESTNewsSyndax Pharmaceuticals, Inc. 2022 Q3 - Results - Earnings Call PresentationN/A
2022-11-04 08:33 ESTNewsSyndax Pharmaceuticals GAAP EPS of -$0.58 beats by $0.07; updates FY22 guidanceN/A
2022-11-02 23:19 ESTNewsSyndax Pharmaceuticals Q3 2022 Earnings PreviewN/A
2022-08-09 08:07 ESTNewsSyndax Pharmaceuticals, Inc. 2022 Q2 - Results - Earnings Call PresentationN/A
2022-08-09 08:07 ESTNewsSyndax Pharmaceuticals GAAP EPS of -$0.62N/A
2022-08-09 08:07 ESTNewsSyndax Pharmaceuticals, Inc. (SNDX) CEO Michael Metzger on Q2 2022 Results - Earnings Call TranscriptN/A
2022-08-08 07:37 ESTNewsSyndax Pharmaceuticals Q2 2022 Earnings PreviewN/A
2022-06-13 12:56 ESTNewsKeith Goldan joins Syndax Pharmaceuticals as CFON/A
2022-05-10 14:01 ESTNewsSyndax Pharmaceuticals, Inc. 2022 Q1 - Results - Earnings Call PresentationN/A
2022-05-10 14:01 ESTNewsSyndax Pharmaceuticals, Inc. (SNDX) CEO Michael Metzger on Q1 2022 Results - Earnings Call TranscriptN/A
2022-05-09 16:51 ESTNewsSyndax Pharmaceuticals GAAP EPS of -$0.63N/A
2022-05-09 00:26 ESTNewsSyndax Pharmaceuticals Q1 2022 Earnings PreviewN/A
2022-04-08 05:11 ESTNewsSyndax Pharmaceuticals: Cash-Rich With 2 Promising DrugsN/A
2022-03-25 00:25 ESTNewsSyndax Pharmaceuticals (SNDX) Presents At Barclays Global Healthcare ConferenceN/A
2022-03-02 06:49 ESTNewsSyndax appoints former Alnylam executive as new medical chiefN/A
2022-03-02 06:49 ESTNewsSyndax Pharmaceuticals GAAP EPS of $1.81 beats by $1.84, revenue of $126.6M beats by $67.92MN/A
2022-03-02 06:48 ESTNewsSyndax Pharmaceuticals, Inc. (SNDX) CEO Michael Metzger on Q4 2021 Results - Earnings Call TranscriptN/A
2022-02-28 18:56 ESTNewsSyndax Pharmaceuticals Q4 Earnings PreviewN/A
2022-01-29 06:36 ESTNewsSyndax Pharmaceuticals (SNDX) Investor Presentation - SlideshowN/A
2021-12-23 00:22 ESTNewsSyndax's SNDX-5613 an Orphan Drug in Europe for acute myeloid leukemiaN/A
2021-12-16 14:02 ESTNewsSyndax Pharma raises $75M via stock offeringN/A
2021-12-15 18:28 ESTNewsSyndax Pharmaceuticals drops 6% following underwritten stock offeringN/A
2021-11-16 08:01 ESTNewsSyndax Pharmaceuticals EPS misses by $0.35, misses on revenueN/A
2021-11-16 08:01 ESTNewsSyndax Pharmaceuticals, Inc. (SNDX) CEO Briggs Morrison on Q3 2021 Results - Earnings Call TranscriptN/A
2021-11-16 08:01 ESTNewsSyndax Pharmaceuticals, Inc. 2021 Q3 - Results - Earnings Call PresentationN/A
2021-11-14 18:13 ESTNewsSyndax Pharmaceuticals Q3 2021 Earnings PreviewN/A
2021-11-04 16:35 ESTNewsSyndax Pharma falls after updating early-stage data for leukemia therapyN/A
2021-10-05 15:59 ESTNewsSyndax Pharma CFO Daphne Karydas to resign to pursue another opportunityN/A
2021-09-28 02:06 ESTNewsIncyte and Syndax in pact for xatilimab targeting immune-related conditionsN/A
2021-08-10 12:01 ESTNewsSyndax Pharmaceuticals EPS beats by $0.28, beats on revenueN/A
2021-08-10 12:00 ESTNewsSyndax Pharmaceuticals, Inc. (SNDX) CEO Briggs Morrison on Q2 2021 Results - Earnings Call TranscriptN/A
2021-08-10 11:59 ESTNewsSyndax Pharmaceuticals, Inc. 2021 Q2 - Results - Earnings Call PresentationN/A
2021-07-22 02:04 ESTNewsSyndax Pharmaceuticals: Updated Analysis After Reporting Interim Phase 1 DataN/A
2021-07-22 02:02 ESTNewsCanopy upgraded on economy reopening, Xeris PT cut on acquisition news, and more in analyst actionN/A
2021-07-22 01:35 ESTNewsSyndax shares rise on FDA Fast Track status for leukemia treatment SNDX-5613N/A

About Syndax Pharmaceuticals, Inc (SNDX):

Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 protein for the treatment of MLL-rearranged (MLLr) and nucleophosmin 1 mutant acute myeloid leukemia (NPM1c AML); and SNDX-6352 or axatilimab, a monoclonal antibody that blocks the colony stimulating factor 1, or CSF-1 receptor for the treatment of patients with chronic graft versus host disease (cGVHD). The company is also developing Entinostat. It also has collaborative research and development agreement with National Cancer Institute; a clinical trial agreement with Eastern Cooperative Oncology Group; and a license agreement with Kyowa Hakko Kirin Co., Ltd. The company was incorporated in 2005 and is headquartered in Waltham, Massachusetts.

See Advanced Chart

General

  • Name Syndax Pharmaceuticals, Inc
  • Symbol SNDX
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 43
  • Fiscal Year EndDecember
  • IPO Date2016-03-03
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryBiotechnology
  • Gic SubIndustryBiotechnology
  • Web URLhttp://www.syndax.com
View More

Valuation

  • Price/Sales (Trailing 12 Mt.) 634.74
  • Price/Book (Most Recent Quarter) 4.43
  • Enterprise Value Revenue 542.55
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate -$2.19
  • Next Year EPS Estimate -$2.17
  • Next Quarter EPS Estimate -$0.47
  • Operating Margin -4708%
  • Return on Assets -25%
  • Return on Equity -52%
  • Revenue 1.52 million
  • Earnings Per Share -$2.36
  • Revenue Per Share $0.04
  • Gross Profit 1.52 million
  • Quarterly Earnings Growth 0%
View More

Highlights

  • Market Capitalization 1.16 billion
  • EBITDA -67280000
  • PE Ratio -125.39
  • Analyst Target Price $32.14
  • Book Value Per Share $5.27
View More

Share Statistics

  • Shares Outstanding 48.24 million
  • Shares Float 42.95 million
  • % Held by Insiders 645%
  • % Held by Institutions 78.88%
  • Shares Short 4.93 million
  • Shares Short Prior Month 4.93 million
  • Short Ratio 9.27
  • Short % of Float 11%
  • Short % of Shares Outstanding 10%
View More

Technicals

  • Beta 1.84
  • 52 Week High $27.12
  • 52 Week Low $8.18
  • 50 Day Moving Average 22.33
  • 200 Day Moving Average 20.55
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Syndax Pharmaceuticals, Inc (SNDX) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Syndax Pharmaceuticals, Inc (SNDX) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-03-08$380000-$0.44-$0.5113.23%
2020-09-302020-11-02$N/A-$0.46-$0.43-6.75%
2020-06-302020-08-06$N/A-$0.42-$0.444.76%
2020-03-312020-05-07$379000-$0.56-$0.53-6.65%
2019-12-312020-03-03$380000-$0.44-$0.43-1.31%
2019-09-302019-11-07$379000-$0.41-$0.4813.92%
2019-06-302019-08-07$379000-$0.47-$0.470.76%
2019-03-312019-05-06$379000-$0.53-$0.554.14%
2018-12-312019-03-07$379000-$0.70-$0.64-9.43%
2018-09-302018-11-05$379000-$0.68-$0.7610.21%
2018-06-302018-08-07$379000-$0.74-$0.8916.94%
2018-03-312018-05-08$379000-$0.79-$0.9517.15%
2017-12-312018-03-05$1.19 million-$0.80-$0.77-3.67%
2017-09-302017-11-07$305000-$0.68-$0.8216.63%
2017-06-302017-08-10$305000-$0.70-$0.8214.83%
2017-03-312017-05-08$305000-$0.71-$0.710.56%
2016-12-312017-03-02$305000-$0.59-$0.7419.79%
2016-09-302016-11-10$305000-$0.84-$0.82-2.78%
2016-06-302016-08-09$305000-$0.47-$0.5412.18%
2016-03-312016-05-16$305000-$0.73-$0.48-52.22%

Syndax Pharmaceuticals, Inc (SNDX) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Syndax Pharmaceuticals, Inc (SNDX) Chart:

Syndax Pharmaceuticals, Inc (SNDX) News:

Below you will find a list of latest news for Syndax Pharmaceuticals, Inc (SNDX) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Syndax Pharmaceuticals, Inc (SNDX) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2026-05-15150CALL0 3197.61TRUE00
2026-05-15160CALL0 085.49TRUE00
2026-05-15170CALL0 00TRUE00
2026-05-15180CALL0 053.8TRUE00
2026-05-15190CALL0 061.44TRUE00
2026-05-15200CALL0 3080.24TRUE00
2026-05-15210CALL0 071.13TRUE00
2026-05-15220CALL0 066.29TRUE00
2026-05-15230CALL0 457.98TRUE00
2026-05-15241.8CALL11 1169.4FALSE-0.3-0.14
2026-05-15251.4CALL12 19669.72FALSE-0.8-0.36
2026-05-15261.34CALL0 17777.82FALSE00
2026-05-15271.24CALL0 3761.88FALSE00
2026-05-15280CALL0 076.88FALSE00
2026-05-15290CALL0 1120.07FALSE00
2026-05-15300.55CALL0 4093.61FALSE00
2026-05-15310.32CALL0 993.31FALSE00
2026-05-15320.2CALL5 073.26FALSE0.20
2026-05-15350CALL0 0110.69FALSE00
2026-05-15150PUT0 0276.67FALSE00
2026-05-15160PUT0 0197.87FALSE00
2026-05-15170PUT0 0148.28FALSE00
2026-05-15180PUT0 0138.7FALSE00
2026-05-15190PUT0 0186.36FALSE00
2026-05-15200PUT0 1169.54FALSE00
2026-05-15210PUT0 2149.67FALSE00
2026-05-15220PUT0 3134.11FALSE00
2026-05-15231.5PUT9 3572.53FALSE0.350.3
2026-05-15240PUT0 191.87TRUE00
2026-05-15252.25PUT0 10265TRUE00
2026-05-15260PUT0 067.05TRUE00
2026-05-15270PUT0 064.13TRUE00
2026-05-15280PUT0 063.65TRUE00
2026-05-15290PUT0 066.05TRUE00
2026-05-15300PUT0 058.43TRUE00
2026-05-15310PUT0 073.11TRUE00
2026-05-15320PUT0 075.08TRUE00
2026-05-15350PUT0 00TRUE00
2026-06-18160CALL0 068.13TRUE00
2026-06-18170CALL0 063.05TRUE00
2026-06-18180CALL0 065.75TRUE00
2026-06-18190CALL0 069.23TRUE00
2026-06-18200CALL0 068.78TRUE00
2026-06-18210CALL0 066.56TRUE00
2026-06-18220CALL0 068.56TRUE00
2026-06-18230CALL0 067.98TRUE00
2026-06-18240CALL0 063.98FALSE00
2026-06-18250CALL0 073.78FALSE00
2026-06-18260CALL0 082.91FALSE00
2026-06-18270CALL0 091.09FALSE00
2026-06-18280CALL0 098.54FALSE00
2026-06-18290CALL0 0103.46FALSE00
2026-06-18300CALL0 0109.82FALSE00
2026-06-18310CALL0 0115.76FALSE00
2026-06-18320CALL0 0121.35FALSE00
2026-06-18160PUT0 0115.41FALSE00
2026-06-18170PUT0 0112.64FALSE00
2026-06-18180PUT0 0102.36FALSE00
2026-06-18190PUT0 093.14FALSE00
2026-06-18200PUT0 079.84FALSE00
2026-06-18210PUT0 073.75FALSE00
2026-06-18220PUT0 061.32FALSE00
2026-06-18230PUT0 075.79FALSE00
2026-06-18240PUT0 062.05TRUE00
2026-06-18250PUT0 064.97TRUE00
2026-06-18260PUT0 063.24TRUE00
2026-06-18270PUT0 064TRUE00
2026-06-18280PUT0 064.9TRUE00
2026-06-18290PUT0 059.22TRUE00
2026-06-18300PUT0 057.92TRUE00
2026-06-18310PUT0 066.64TRUE00
2026-06-18320PUT0 071.5TRUE00
2026-07-1750CALL0 0164.81TRUE00
2026-07-1790CALL0 097.1TRUE00
2026-07-17100CALL0 085.06TRUE00
2026-07-17110CALL0 074.09TRUE00
2026-07-17120CALL0 374.85TRUE00
2026-07-17130CALL0 072.63TRUE00
2026-07-17140CALL0 780.89TRUE00
2026-07-17150CALL0 771.85TRUE00
2026-07-17160CALL0 068.89TRUE00
2026-07-17170CALL0 269.39TRUE00
2026-07-17180CALL0 9862.63TRUE00
2026-07-17190CALL0 070.09TRUE00
2026-07-17200CALL0 964.16TRUE00
2026-07-17210CALL0 767.24TRUE00
2026-07-17220CALL0 1367.44TRUE00
2026-07-17233.78CALL0 1765.92TRUE00
2026-07-17243.08CALL5 20764.58FALSE3.080
2026-07-17252.5CALL110 7060.98FALSE2.50
2026-07-17260CALL0 7670.68FALSE00
2026-07-17270CALL0 068.5FALSE00
2026-07-17281.9CALL0 8168.7FALSE00
2026-07-17290CALL0 258.93FALSE00
2026-07-17301CALL1 9358.26FALSE-0.48-0.32
2026-07-17310CALL0 165.89FALSE00
2026-07-17320CALL0 171.39FALSE00
2026-07-17330CALL0 564.45FALSE00
2026-07-17340CALL0 081.81FALSE00
2026-07-17350CALL0 281.47FALSE00
2026-07-1750PUT0 0278.46FALSE00
2026-07-1790PUT0 0178.64FALSE00
2026-07-17100PUT0 0192.63FALSE00
2026-07-17110PUT0 0181.53FALSE00
2026-07-17120PUT0 0119.44FALSE00
2026-07-17130PUT0 0112.26FALSE00
2026-07-17140PUT0 090.94FALSE00
2026-07-17150PUT0 0121.97FALSE00
2026-07-17160PUT0 1113FALSE00
2026-07-17170PUT0 561.23FALSE00
2026-07-17180PUT0 855.7FALSE00
2026-07-17190PUT0 3352.68FALSE00
2026-07-17200PUT0 059.7FALSE00
2026-07-17210PUT0 1246.85FALSE00
2026-07-17220PUT0 060.58FALSE00
2026-07-17230PUT0 160.07FALSE00
2026-07-17240PUT0 462.63TRUE00
2026-07-17254.4PUT7 1080.3TRUE4.40
2026-07-17260PUT0 065.91TRUE00
2026-07-17270PUT0 068.02TRUE00
2026-07-17280PUT0 061.62TRUE00
2026-07-17290PUT0 062.55TRUE00
2026-07-17300PUT0 062.74TRUE00
2026-07-17310PUT0 059.43TRUE00
2026-07-17320PUT0 065.03TRUE00
2026-07-17330PUT0 164.59TRUE00
2026-07-17340PUT0 063.37TRUE00
2026-07-17350PUT0 058.86TRUE00
2026-08-21110CALL0 074.11TRUE00
2026-08-21120CALL0 065.11TRUE00
2026-08-21130CALL0 080.77TRUE00
2026-08-21140CALL0 084.18TRUE00
2026-08-21150CALL0 071.06TRUE00
2026-08-21160CALL0 070.72TRUE00
2026-08-21170CALL0 072.22TRUE00
2026-08-21180CALL0 066.67TRUE00
2026-08-21190CALL0 067.28TRUE00
2026-08-21200CALL0 267.82TRUE00
2026-08-21210CALL0 265.73TRUE00
2026-08-21220CALL0 074.71TRUE00
2026-08-21230CALL0 068.49TRUE00
2026-08-21240CALL0 372.41FALSE00
2026-08-21253.58CALL0 30175.95FALSE00
2026-08-21260CALL0 169.41FALSE00
2026-08-21270CALL0 1665.88FALSE00
2026-08-21280CALL0 070.74FALSE00
2026-08-21290CALL0 563.68FALSE00
2026-08-21300CALL0 063.32FALSE00
2026-08-21310CALL0 081.18FALSE00
2026-08-21320CALL0 077.55FALSE00
2026-08-21350CALL0 066.64FALSE00
2026-08-21110PUT0 070.41FALSE00
2026-08-21120PUT0 074.57FALSE00
2026-08-21130PUT0 082.13FALSE00
2026-08-21140PUT0 0116.49FALSE00
2026-08-21150PUT0 065.21FALSE00
2026-08-21160PUT0 072.87FALSE00
2026-08-21170PUT0 059.08FALSE00
2026-08-21180PUT0 077.57FALSE00
2026-08-21190PUT0 156.39FALSE00
2026-08-21201.92PUT0 30162.3FALSE00
2026-08-21210PUT0 055.04FALSE00
2026-08-21220PUT0 1173.18FALSE00
2026-08-21230PUT0 063.45FALSE00
2026-08-21240PUT0 472.67TRUE00
2026-08-21250PUT0 665.1TRUE00
2026-08-21260PUT0 074.84TRUE00
2026-08-21270PUT0 063.79TRUE00
2026-08-21280PUT0 072.84TRUE00
2026-08-21290PUT0 073.3TRUE00
2026-08-21300PUT0 070.45TRUE00
2026-08-21310PUT0 064.89TRUE00
2026-08-21320PUT0 065.65TRUE00
2026-08-21350PUT0 061.43TRUE00
2026-09-18110CALL0 074.59TRUE00
2026-09-18120CALL0 065.97TRUE00
2026-09-18130CALL0 081.34TRUE00
2026-09-18140CALL0 074.93TRUE00
2026-09-18150CALL0 072.39TRUE00
2026-09-18160CALL0 069.3TRUE00
2026-09-18170CALL0 073.82TRUE00
2026-09-18180CALL0 068.08TRUE00
2026-09-18190CALL0 066.75TRUE00
2026-09-18200CALL0 065.75TRUE00
2026-09-18210CALL0 067.79TRUE00
2026-09-18220CALL0 067.09TRUE00
2026-09-18230CALL0 867.45TRUE00
2026-09-18240CALL0 067.98FALSE00
2026-09-18250CALL0 1068.31FALSE00
2026-09-18260CALL0 174.56FALSE00
2026-09-18270CALL0 072.59FALSE00
2026-09-18280CALL0 062.85FALSE00
2026-09-18290CALL0 061.07FALSE00
2026-09-18300CALL0 062.17FALSE00
2026-09-18310CALL0 077.75FALSE00
2026-09-18320CALL0 066.81FALSE00
2026-09-18350CALL0 069.64FALSE00
2026-09-18110PUT0 070.13FALSE00
2026-09-18120PUT0 075.03FALSE00
2026-09-18130PUT0 0137.59FALSE00
2026-09-18140PUT0 067.26FALSE00
2026-09-18150PUT0 061.46FALSE00
2026-09-18160PUT0 062.99FALSE00
2026-09-18170PUT0 056.91FALSE00
2026-09-18180PUT0 053.75FALSE00
2026-09-18190PUT0 150.77FALSE00
2026-09-18202.1PUT0 254.7FALSE00
2026-09-18210PUT0 055.45FALSE00
2026-09-18220PUT0 063.61FALSE00
2026-09-18230PUT0 071.53FALSE00
2026-09-18240PUT0 071.29TRUE00
2026-09-18250PUT0 062.33TRUE00
2026-09-18260PUT0 065.92TRUE00
2026-09-18270PUT0 054.29TRUE00
2026-09-18280PUT0 060.04TRUE00
2026-09-18290PUT0 063.75TRUE00
2026-09-18300PUT0 062.84TRUE00
2026-09-18310PUT0 064.99TRUE00
2026-09-18320PUT0 061.29TRUE00
2026-09-18350PUT0 063.69TRUE00
2026-10-16110CALL0 074.11TRUE00
2026-10-16120CALL0 079.71TRUE00
2026-10-16130CALL0 281.59TRUE00
2026-10-16140CALL0 076.7TRUE00
2026-10-16150CALL0 2065.49TRUE00
2026-10-16160CALL0 072.4TRUE00
2026-10-16170CALL0 070.69TRUE00
2026-10-16180CALL0 068.42TRUE00
2026-10-16190CALL0 071.61TRUE00
2026-10-16200CALL0 469.97TRUE00
2026-10-16210CALL0 069.57TRUE00
2026-10-16220CALL0 069.41TRUE00
2026-10-16230CALL0 069.49TRUE00
2026-10-16240CALL0 068.64FALSE00
2026-10-16250CALL0 1867.34FALSE00
2026-10-16260CALL0 067.48FALSE00
2026-10-16270CALL0 068.29FALSE00
2026-10-16280CALL0 053.72FALSE00
2026-10-16290CALL0 061.59FALSE00
2026-10-16300CALL0 067.67FALSE00
2026-10-16310CALL0 068.17FALSE00
2026-10-16320CALL0 071.5FALSE00
2026-10-16350CALL0 079.22FALSE00
2026-10-16110PUT0 067.12FALSE00
2026-10-16120PUT0 064.38FALSE00
2026-10-16130PUT0 061.11FALSE00
2026-10-16140PUT0 087.47FALSE00
2026-10-16150PUT0 559.66FALSE00
2026-10-16160PUT0 056.68FALSE00
2026-10-16170PUT0 554.05FALSE00
2026-10-16180PUT0 052.82FALSE00
2026-10-16190PUT0 049.77FALSE00
2026-10-16200PUT0 048.29FALSE00
2026-10-16210PUT0 049.23FALSE00
2026-10-16220PUT0 10067.56FALSE00
2026-10-16230PUT0 066.32FALSE00
2026-10-16240PUT0 066.9TRUE00
2026-10-16250PUT0 065.42TRUE00
2026-10-16260PUT0 065.73TRUE00
2026-10-16270PUT0 063.34TRUE00
2026-10-16280PUT0 064.23TRUE00
2026-10-16290PUT0 062.45TRUE00
2026-10-16300PUT0 065.63TRUE00
2026-10-16310PUT0 060.6TRUE00
2026-10-16320PUT0 065.63TRUE00
2026-10-16350PUT0 063.46TRUE00
2027-01-1530CALL0 0118.27TRUE00
2027-01-1550CALL0 098.11TRUE00
2027-01-1580CALL0 1785.12TRUE00
2027-01-15100CALL0 4482.09TRUE00
2027-01-15130CALL0 8077.17TRUE00
2027-01-15150CALL0 17074.93TRUE00
2027-01-15170CALL0 675.38TRUE00
2027-01-15200CALL0 14274.33TRUE00
2027-01-15227CALL2 340274.44TRUE0.020
2027-01-15250CALL0 3879.69FALSE00
2027-01-15270CALL0 7174.41FALSE00
2027-01-15300CALL0 4071.58FALSE00
2027-01-15320CALL0 070.99FALSE00
2027-01-15353.5CALL0 1770.1FALSE00
2027-01-15370CALL0 068.65FALSE00
2027-01-15400CALL0 24873.76FALSE00
2027-01-1530PUT0 0195.34FALSE00
2027-01-1550PUT0 0142.55FALSE00
2027-01-1580PUT0 075.11FALSE00
2027-01-15100PUT0 0126.73FALSE00
2027-01-15130PUT0 562.38FALSE00
2027-01-15150PUT0 1562.07FALSE00
2027-01-15170PUT0 054.45FALSE00
2027-01-15200PUT0 156.09FALSE00
2027-01-15220PUT0 070.53FALSE00
2027-01-15250PUT0 10467.28TRUE00
2027-01-15270PUT0 070.43TRUE00
2027-01-15300PUT0 8968.47TRUE00
2027-01-15320PUT0 069.69TRUE00
2027-01-15350PUT0 069.42TRUE00
2027-01-15370PUT0 066.7TRUE00
2027-01-15400PUT0 767.77TRUE00
2028-01-2130CALL0 143.55TRUE00
2028-01-2150CALL0 085.89TRUE00
2028-01-2180CALL0 072.98TRUE00
2028-01-21100CALL0 3975.23TRUE00
2028-01-21130CALL0 174.94TRUE00
2028-01-21150CALL0 075.1TRUE00
2028-01-21170CALL0 2774.04TRUE00
2028-01-21200CALL0 10171.12TRUE00
2028-01-21220CALL0 373.41TRUE00
2028-01-21258.82CALL11 2871.45FALSE-0.43-0.05
2028-01-21278.5CALL1 5073.7FALSE8.50
2028-01-21300CALL0 10273.82FALSE00
2028-01-21320CALL0 073.48FALSE00
2028-01-21350CALL0 672.43FALSE00
2028-01-21376CALL1 5071.43FALSE60
2028-01-21400CALL0 3772.29FALSE00
2028-01-2130PUT0 0296.05FALSE00
2028-01-2150PUT0 0176.34FALSE00
2028-01-2180PUT0 0120.53FALSE00
2028-01-21100PUT0 399.19FALSE00
2028-01-21132.5PUT0 7094.62FALSE00
2028-01-21150PUT0 271.02FALSE00
2028-01-21170PUT0 2971.64FALSE00
2028-01-21200PUT0 070.55FALSE00
2028-01-21220PUT0 273.72FALSE00
2028-01-21258.67PUT11 2871.56TRUE0.020
2028-01-21270PUT0 071.46TRUE00
2028-01-21300PUT0 070.52TRUE00
2028-01-21320PUT0 070.77TRUE00
2028-01-21350PUT0 168.51TRUE00
2028-01-21370PUT0 067.94TRUE00
2028-01-21400PUT0 2968.56TRUE00

Latest SNDX Trades:

Date Shares Price
Jun 13, 2022 7:59 PM EST3$15.6
Jun 13, 2022 7:59 PM EST4$15.6
Jun 13, 2022 7:59 PM EST1$15.6
Jun 13, 2022 7:59 PM EST100$15.61
Jun 13, 2022 7:59 PM EST45$15.61

Syndax Pharmaceuticals, Inc (SNDX) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-06-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1395937/000156459020028764/0001564590-20-028764-index.htm
2019-09-05UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1395937/000000000019013216/0000000000-19-013216-index.htm
2019-02-08SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1395937/000021545719006549/0000215457-19-006549-index.htm
2020-02-06SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1395937/000083423720006818/0000834237-20-006818-index.htm
2020-09-09SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1395937/000083423720010194/0000834237-20-010194-index.htm
2019-02-12SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1395937/000090221919000254/0000902219-19-000254-index.htm
2020-01-28SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1395937/000090221920000308/0000902219-20-000308-index.htm
2019-04-08SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1395937/000090266419001816/0000902664-19-001816-index.htm
2020-02-12SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1395937/000090266420000971/0000902664-20-000971-index.htm
2020-11-04SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1395937/000091957420006675/0000919574-20-006675-index.htm
2018-06-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1395937/000092189518001976/0000921895-18-001976-index.htm
2018-11-29SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1395937/000092189518003173/0000921895-18-003173-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1395937/000092189519000467/0000921895-19-000467-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1395937/000092189520000574/0000921895-20-000574-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1395937/000101359419000160/0001013594-19-000160-index.htm
2020-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1395937/000101359420000127/0001013594-20-000127-index.htm
2018-04-10DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1395937/000114036118018005/0001140361-18-018005-index.htm
2018-04-10DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1395937/000114036118018007/0001140361-18-018007-index.htm
2018-06-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1395937/000119312518197997/0001193125-18-197997-index.htm
2019-02-12SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1395937/000119312519034379/0001193125-19-034379-index.htm
2019-03-28424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1395937/000119312519088951/0001193125-19-088951-index.htm
2019-03-298-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1395937/000119312519092679/0001193125-19-092679-index.htm
2019-03-29424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1395937/000119312519092701/0001193125-19-092701-index.htm
2019-08-30S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1395937/000119312519235283/0001193125-19-235283-index.htm
2019-09-06CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1395937/000119312519239953/0001193125-19-239953-index.htm
2019-09-10424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1395937/000119312519242045/0001193125-19-242045-index.htm
2019-10-09SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1395937/000119312519265254/0001193125-19-265254-index.htm
2020-02-03424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1395937/000119312520022917/0001193125-20-022917-index.htm
2020-02-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1395937/000119312520023646/0001193125-20-023646-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1395937/000119312520037637/0001193125-20-037637-index.htm
2020-05-11SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1395937/000119312520139263/0001193125-20-139263-index.htm
2018-04-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1395937/000156218018001800/0001562180-18-001800-index.htm
2018-05-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1395937/000156218018002680/0001562180-18-002680-index.htm
2018-05-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1395937/000156218018002681/0001562180-18-002681-index.htm
2018-05-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1395937/000156218018002682/0001562180-18-002682-index.htm
2018-05-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1395937/000156218018002683/0001562180-18-002683-index.htm
2018-05-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1395937/000156218018002684/0001562180-18-002684-index.htm
2018-05-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1395937/000156218018002685/0001562180-18-002685-index.htm
2018-09-273Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1395937/000156218018004047/0001562180-18-004047-index.htm
2018-09-273Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1395937/000156218018004048/0001562180-18-004048-index.htm
2018-09-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1395937/000156218018004049/0001562180-18-004049-index.htm
2018-09-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1395937/000156218018004050/0001562180-18-004050-index.htm
2018-11-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1395937/000156218018004443/0001562180-18-004443-index.htm
2019-02-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1395937/000156218019000852/0001562180-19-000852-index.htm
2019-02-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1395937/000156218019000853/0001562180-19-000853-index.htm
2019-02-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1395937/000156218019000854/0001562180-19-000854-index.htm
2019-02-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1395937/000156218019000855/0001562180-19-000855-index.htm
2019-02-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1395937/000156218019000856/0001562180-19-000856-index.htm
2019-03-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1395937/000156218019002012/0001562180-19-002012-index.htm
2019-03-254/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1395937/000156218019002023/0001562180-19-002023-index.htm
2019-05-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1395937/000156218019002780/0001562180-19-002780-index.htm
2019-06-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1395937/000156218019003487/0001562180-19-003487-index.htm
2019-06-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1395937/000156218019003488/0001562180-19-003488-index.htm
2019-06-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1395937/000156218019003489/0001562180-19-003489-index.htm
2019-06-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1395937/000156218019003490/0001562180-19-003490-index.htm
2019-06-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1395937/000156218019003491/0001562180-19-003491-index.htm
2019-06-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1395937/000156218019003492/0001562180-19-003492-index.htm
2019-07-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1395937/000156218019003880/0001562180-19-003880-index.htm
2019-10-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1395937/000156218019005140/0001562180-19-005140-index.htm
2020-02-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1395937/000156218020000891/0001562180-20-000891-index.htm
2020-02-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1395937/000156218020001228/0001562180-20-001228-index.htm
2020-02-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1395937/000156218020001229/0001562180-20-001229-index.htm
2020-02-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1395937/000156218020001230/0001562180-20-001230-index.htm
2020-02-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1395937/000156218020001231/0001562180-20-001231-index.htm
2020-02-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1395937/000156218020001232/0001562180-20-001232-index.htm
2020-02-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1395937/000156218020001233/0001562180-20-001233-index.htm
2020-02-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1395937/000156218020001234/0001562180-20-001234-index.htm
2020-02-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1395937/000156218020001235/0001562180-20-001235-index.htm
2020-02-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1395937/000156218020001236/0001562180-20-001236-index.htm
2020-02-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1395937/000156218020001237/0001562180-20-001237-index.htm
2020-02-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1395937/000156218020001238/0001562180-20-001238-index.htm
2020-07-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1395937/000156218020005074/0001562180-20-005074-index.htm
2020-07-133Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1395937/000156218020005102/0001562180-20-005102-index.htm
2020-11-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1395937/000156218020006583/0001562180-20-006583-index.htm
2018-03-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1395937/000156459018004520/0001564590-18-004520-index.htm
2018-03-0810-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1395937/000156459018004911/0001564590-18-004911-index.htm
2018-05-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1395937/000156459018011784/0001564590-18-011784-index.htm
2018-05-0910-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1395937/000156459018012378/0001564590-18-012378-index.htm
2018-05-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1395937/000156459018014349/0001564590-18-014349-index.htm
2018-08-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1395937/000156459018019907/0001564590-18-019907-index.htm
2018-08-0810-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1395937/000156459018020483/0001564590-18-020483-index.htm
2018-08-08S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1395937/000156459018020504/0001564590-18-020504-index.htm
2018-09-268-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1395937/000156459018023593/0001564590-18-023593-index.htm
2018-11-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1395937/000156459018026817/0001564590-18-026817-index.htm
2018-11-0510-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1395937/000156459018026892/0001564590-18-026892-index.htm
2019-02-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1395937/000156459019002676/0001564590-19-002676-index.htm
2019-03-0710-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1395937/000156459019006772/0001564590-19-006772-index.htm
2019-03-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1395937/000156459019006777/0001564590-19-006777-index.htm
2019-03-1810-K/AAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1395937/000156459019008313/0001564590-19-008313-index.htm
2019-04-30DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1395937/000156459019014263/0001564590-19-014263-index.htm
2019-05-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1395937/000156459019015972/0001564590-19-015972-index.htm
2019-05-0810-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1395937/000156459019017318/0001564590-19-017318-index.htm
2019-06-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1395937/000156459019022241/0001564590-19-022241-index.htm
2019-07-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1395937/000156459019024625/0001564590-19-024625-index.htm
2019-08-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1395937/000156459019030050/0001564590-19-030050-index.htm
2019-08-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1395937/000156459019030067/0001564590-19-030067-index.htm
2019-08-07S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1395937/000156459019030084/0001564590-19-030084-index.htm
2019-10-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1395937/000156459019036518/0001564590-19-036518-index.htm
2019-11-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1395937/000156459019041712/0001564590-19-041712-index.htm
2019-11-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1395937/000156459019041719/0001564590-19-041719-index.htm
2019-12-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1395937/000156459019045581/0001564590-19-045581-index.htm
2020-02-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1395937/000156459020004037/0001564590-20-004037-index.htm
2020-02-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1395937/000156459020005551/0001564590-20-005551-index.htm
2020-03-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1395937/000156459020008426/0001564590-20-008426-index.htm
2020-03-0510-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1395937/000156459020009016/0001564590-20-009016-index.htm
2020-04-29DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1395937/000156459020019694/0001564590-20-019694-index.htm
2020-04-30424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1395937/000156459020019928/0001564590-20-019928-index.htm
2020-04-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1395937/000156459020019941/0001564590-20-019941-index.htm
2020-05-04424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1395937/000156459020020574/0001564590-20-020574-index.htm
2020-05-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1395937/000156459020020633/0001564590-20-020633-index.htm
2020-05-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1395937/000156459020022849/0001564590-20-022849-index.htm
2020-05-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1395937/000156459020022971/0001564590-20-022971-index.htm
2020-06-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1395937/000156459020028764/0001564590-20-028764-index.htm
2020-07-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1395937/000156459020031882/0001564590-20-031882-index.htm
2020-08-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1395937/000156459020037719/0001564590-20-037719-index.htm
2020-08-06S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1395937/000156459020037767/0001564590-20-037767-index.htm
2020-08-0610-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1395937/000156459020037777/0001564590-20-037777-index.htm
2020-11-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1395937/000156459020049638/0001564590-20-049638-index.htm
2020-11-0510-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1395937/000156459020051287/0001564590-20-051287-index.htm
2019-09-10EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1395937/999999999519002056/9999999995-19-002056-index.htm
2018-11-27CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1395937/999999999716026189/9999999997-16-026189-index.htm
2018-04-03CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1395937/999999999718004150/9999999997-18-004150-index.htm
2018-06-13CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1395937/999999999718006372/9999999997-18-006372-index.htm
2018-08-29CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1395937/999999999718007508/9999999997-18-007508-index.htm
2018-12-20CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1395937/999999999718009113/9999999997-18-009113-index.htm
2019-03-28CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1395937/999999999719002097/9999999997-19-002097-index.htm

Syndax Pharmaceuticals, Inc (SNDX) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Syndax Pharmaceuticals, Inc (SNDX). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 645%
Institutional Ownership: 7888%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2018-04-03Peter OrdentlichChief Scientific OfficerSell7,500.0015.00112,500.000.00https://www.sec.gov/Archives/edgar/data/1395937/000156218018001800/0001562180-18-001800-index.htm
2020-07-06Michael L. MeyersSVP, Chief Medical OfficerBuy3,500.0010,730.00https://www.sec.gov/Archives/edgar/data/1395937/000156218020005074/0001562180-20-005074-index.htm
2020-11-04Michael A MetzgerPresident and COOBuy100,000.007.20720,000.00117,659.00https://www.sec.gov/Archives/edgar/data/1395937/000156218020006583/0001562180-20-006583-index.htm
2019-05-09Briggs MorrisonChief Executive OfficerBuy13,200.007.5699,726.0013,200.00https://www.sec.gov/Archives/edgar/data/1395937/000156218019002780/0001562180-19-002780-index.htm
2020-02-12Michael A MetzgerPresident and COOBuy15,000.0017,659.00https://www.sec.gov/Archives/edgar/data/1395937/000156218020001238/0001562180-20-001238-index.htm
2020-11-04Michael A MetzgerPresident and COOSell100,000.0020.312,031,410.0017,659.00https://www.sec.gov/Archives/edgar/data/1395937/000156218020006583/0001562180-20-006583-index.htm
2019-05-13Briggs MorrisonChief Executive OfficerBuy7,200.007.2952,516.8020,400.00https://www.sec.gov/Archives/edgar/data/1395937/000156218019002780/0001562180-19-002780-index.htm
2018-10-30Michael L. MeyersSVP, Chief Medical OfficerBuy200.004.79958.002,398.00https://www.sec.gov/Archives/edgar/data/1395937/000156218018004443/0001562180-18-004443-index.htm
2019-10-10Briggs MorrisonChief Executive OfficerBuy11,000.005.4059,400.0031,400.00https://www.sec.gov/Archives/edgar/data/1395937/000156218019005140/0001562180-19-005140-index.htm
2020-02-04Briggs MorrisonChief Executive OfficerBuy12,500.008.00100,000.0043,900.00https://www.sec.gov/Archives/edgar/data/1395937/000156218020000891/0001562180-20-000891-index.htm
2019-03-21Michael L. MeyersSVP, Chief Medical OfficerBuy1,000.004.934,930.007,118.00https://www.sec.gov/Archives/edgar/data/1395937/000156218019002012/0001562180-19-002012-index.htm
2019-03-21Michael L. MeyersSVP, Chief Medical OfficerBuy104.004.87506.487,222.00https://www.sec.gov/Archives/edgar/data/1395937/000156218019002012/0001562180-19-002012-index.htm
2018-04-03Peter OrdentlichChief Scientific OfficerBuy7,500.003.0823,100.007,500.00https://www.sec.gov/Archives/edgar/data/1395937/000156218018001800/0001562180-18-001800-index.htm